- Home
- AFYA vs DYN Comparison
AFYA vs DYN Comparison
Compare AFYA & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AFYA
- DYN
- Stock Information
- Founded
- AFYA 1999
- DYN 1984
- Country
- AFYA Brazil
- DYN United States
- Employees
- AFYA N/A
- DYN N/A
- Industry
- AFYA Other Consumer Services
- DYN Medicinal Chemicals and Botanical Products
- Sector
- AFYA Real Estate
- DYN Health Care
- Exchange
- AFYA Nasdaq
- DYN Nasdaq
- Market Cap
- AFYA 1.6B
- DYN 1.4B
- IPO Year
- AFYA 2019
- DYN 2020
- Fundamental
- Price
- AFYA $15.06
- DYN $12.38
- Analyst Decision
- AFYA Sell
- DYN Strong Buy
- Analyst Count
- AFYA 5
- DYN 15
- Target Price
- AFYA $17.40
- DYN $36.00
- AVG Volume (30 Days)
- AFYA 127.2K
- DYN 3.0M
- Earning Date
- AFYA 08-13-2025
- DYN 07-28-2025
- Dividend Yield
- AFYA 1.54%
- DYN N/A
- EPS Growth
- AFYA 23.45
- DYN N/A
- EPS
- AFYA 1.39
- DYN N/A
- Revenue
- AFYA $650,778,153.00
- DYN N/A
- Revenue This Year
- AFYA $15.42
- DYN N/A
- Revenue Next Year
- AFYA $8.73
- DYN N/A
- P/E Ratio
- AFYA $11.07
- DYN N/A
- Revenue Growth
- AFYA 15.60
- DYN N/A
- 52 Week Low
- AFYA $13.47
- DYN $6.36
- 52 Week High
- AFYA $19.90
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- AFYA 48.88
- DYN 68.72
- Support Level
- AFYA $14.58
- DYN $10.78
- Resistance Level
- AFYA $15.88
- DYN $12.59
- Average True Range (ATR)
- AFYA 0.42
- DYN 0.81
- MACD
- AFYA 0.22
- DYN 0.29
- Stochastic Oscillator
- AFYA 64.79
- DYN 75.76
About AFYA Afya Limited
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.